Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes

Howlett, David R; Richardson, Jill C; Austin, Angela; Parsons, Andrew A; Bate, Simon T; Davies, D.Ceri; Gonzalez, M.Isabel

doi:10.1016/j.brainres.2004.05.029

Cited by 225Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes

Howlett, David R, Richardson, Jill C, Austin, Angela, Parsons, Andrew A, Bate, Simon T, Davies, D.Ceri, Gonzalez, M.Isabel·2004·Brain Research

DOI 10.1016/j.brainres.2004.05.029

Open this paper in CoChat — free account

Abstract

Several transgenic mouse models of Alzheimer's disease (AD) have been developed that exhibit beta-amyloid (Abeta) neuropathology and behavioural deficits. However, not all studies have investigated the relationship between the development of cognitive impairment and neuropathology. Therefore, temporal changes in cognition were investigated in male and female double-mutant APPswexPS1.M146V (TASTPM) transgenic mice using an object recognition test and correlated with the development of cerebral Abeta neuropathology. Both male and female TASTPM mice exhibited similar significant cognitive impairment at 6, 8 and 10 months of age in the object recognition test, compared to wild-type littermates. There was no such cognitive impairment at 3 or 4 months of age. Quantitative immunohistochemistry using a battery of Abeta antibodies demonstrated that cerebral Abeta deposition was first apparent in 3-month-old mice, and it increased with age. The early appearance of cerebral Abeta deposits in the double-transgenic TASTPM mice supports the evidence that mutations in the PS1 gene accelerate Abeta deposition. The cerebral Abeta load was greater in female than in male TASTPM mice at all ages investigated. In the electron microscope, mature Abeta plaques comprising a fibrillar core surrounded by degenerating neurites and reactive glia were first observed in the cortex of TASTPM mice at 6 months of age, the same age at which cognitive impairment became apparent. These results suggest that the cognitive impairment in TASTPM mice is related to the disruption of neural connectivity and not simply Abeta deposition, which first occurs 3 months earlier.

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2004.05.029

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The TASTPM mouse model of AD has amyloid plaques and demonstrates memory deficits, but does not show neurofibrillary tangles.
“For instance, the TASTPM mouse model of AD has amyloid plaques and demonstrates memory deficits, but does not show neurofibrillary tangles (101).”
From The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease (2019) · cites this paper as [101]

The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258 · see citing works
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · see citing works
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · see citing works
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386 · see citing works
Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins
Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023 · see citing works
Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · see citing works
Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys
Meunier, M., Bachevalier, J., Mishkin, M., & Murray, E. A. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05418.1993 · Cited by 900 · see citing works
A Modified Method for Lead Staining of Thin Sections
Sato, T. (1968) · Journal of Electron Microscopy · doi:10.1093/oxfordjournals.jmicro.a049610 · Cited by 820 · see citing works
A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B., et al. (2000) · Nature · doi:10.1038/35050103 · Cited by 740 · see citing works
The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 714 · see citing works
Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68
Chen, H., Lanzetta, K. M., Pascarelle, S. M., & Yahata, N. (2000) · RePEc: Research Papers in Economics · Cited by 680 · see citing works
Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse
Irizarry, M. C., Soriano, F., McNamara, M., Page, K. J., Schenk, D., Games, D., & Hyman, B. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-18-07053.1997 · Cited by 497 · see citing works
Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68
Chen, H., Lanzetta, K. M., Pascarelle, S., & Yahata, N. (2000) · Nature · doi:10.1038/35046031 · Cited by 447 · see citing works
Reversible memory loss in a mouse transgenic model of Alzheimer’s disease
Kotilinek, L. A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B. T., Younkin, S., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06331.2002 · Cited by 420 · see citing works
Rhinal cortex lesions and object recognition in rats.
Mumby, D. G., & Pinel, J. P. J. (1994) · Behavioral Neuroscience · doi:10.1037//0735-7044.108.1.11 · Cited by 412 · see citing works
Perspectives on object-recognition memory following hippocampal damage: lessons from studies in rats
Mumby, D. G. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00367-9 · Cited by 356 · see citing works
Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits
Holcomb, L. A., Gordon, M. N., Jantzen, P., Hsiao, K., Duff, K., & Morgan, D. (1999) · Behavior Genetics · doi:10.1023/a:1021691918517 · Cited by 353 · see citing works
Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat
Ennaceur, A., Neave, N., & Aggleton, J. P. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00006-x · Cited by 351 · see citing works
Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes
Arendash, G. W., King, D. L., Gordon, M. N., Morgan, D., Hatcher, J. M., Hope, C. E., & Diamond, D. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03186-3 · Cited by 349 · see citing works
Rhinal cortex lesions and object recognition in rats.
Mumby, D. G., & Pinel, J. P. J. (1994) · Behavioral Neuroscience · doi:10.1037/0735-7044.108.1.11 · Cited by 348 · see citing works
Amnesia and recognition memory: A re-analysis of psychometric data
Aggleton, J. P., & Shaw, C. (1996) · Neuropsychologia · doi:10.1016/0028-3932(95)00150-6 · Cited by 323 · see citing works
Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome
Smith, D., Stevens, M. E., Sudanagunta, S. P., Bronson, R. T., Makhinson, M., Watabe, A. M., O’Dell, T. J., Fung, J., Weier, H. G., Cheng, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-28 · Cited by 321 · see citing works
Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice
Wang, J., Tanila, H., Puoliväli, J., Kadish, I., & Groen, T. V. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.009 · Cited by 316 · see citing works
Deciphering the Genetic Basis of Alzheimer's Disease
Selkoe, D. J., & Podlisny, M. B. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103022 · Cited by 293 · see citing works
Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice
Larson, J., LYNCH, G. S., Games, D., & Seubert, P. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01698-4 · Cited by 274 · see citing works
Augmented Senile Plaque Load in Aged Female β-Amyloid Precursor Protein-Transgenic Mice
Callahan, M. J., Lipinski, W. J., Bian, F., Durham, R. A., Pack, A., & Walker, L. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64064-3 · Cited by 274 · see citing works
Dissociated effects of perirhinal cortex ablation, fornix transection and amygdalectomy: evidence for multiple memory systems in the primate temporal lobe
Gaffan, D. (1994) · Experimental Brain Research · doi:10.1007/bf00228977 · Cited by 254 · see citing works
Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months
King, D. L., & Arendash, G. W. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00639-x · Cited by 240 · see citing works
Early formation of mature amyloid‐β protein deposits in a mutant APP transgenic model depends on levels of Aβ1–42
Rockenstein, E. M., Mallory, M. E., Mante, M., Sisk, A., & Masliaha, E. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1247 · Cited by 221 · see citing works
Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice
Bondolfi, L., Calhoun, M., Ermini, F., Kuhn, H. G., Wiederhold, K.-H., Walker, L., Staufenbiel, M., & Jucker, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00515.2002 · Cited by 213 · see citing works
Behavioral disturbances in transgenic mice overexpressing the V717F Β-amyloid precursor protein.
Dodart, J., Méziane, H., Mathis, C., Bales, K. R., Paul, S. M., & Ungerer, A. (1999) · Behavioral Neuroscience · doi:10.1037//0735-7044.113.5.982 · Cited by 208 · see citing works
Tissue‐specific control elements of the Thy‐1 gene.
Vidal, M., Morris, R. J., Grosveld, F. G., & Spanopoulou, E. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08180.x · Cited by 207 · see citing works
Expression in brain of amyloid precursor protein mutated in the alpha‐secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice.
Moechars, D., Lorent, K., De Strooper, B., Dewachter, I., & Van Leuven, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00468.x · Cited by 201 · see citing works
Progressive age-related impairment of cognitive behavior in APP23 transgenic mice
Kelly, P. H., Bondolfi, L., Hunziker, D., Schlecht, H. P., Carver, K., Maguire, E., Abramowski, D., Wiederhold, K., Sturchler, C., Jucker, M., et al. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00098-2 · Cited by 187 · see citing works
Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes
McGowan, E. M., Sanders, S., Iwatsubo, T., Takeuchi, A., Saido, T. C., Zehr, C., Yu, X., Uljon, S., Wang, R., Mann, D. M. A., et al. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0243 · Cited by 180 · see citing works
Behavioral disturbances in transgenic mice overexpressing the V717F Β-amyloid precursor protein.
Dodart, J., Méziane, H., Mathis, C., et al. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.5.982 · Cited by 168 · see citing works
FAD mutant PS-1 gene-targeted mice: increased Aβ42 and Aβ deposition without APP overproduction
Flood, D. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00330-x · Cited by 131 · see citing works
Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes
Kurt, M. A., Davies, D. C., Kidd, M., Duff, K., Rolph, S. C., JENNINGS, K. H., & Howlett, D. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7717 · Cited by 88 · see citing works
Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer’s disease
Richardson, J. C., Kendal, C., Anderson, R., Priest, F., Gower, E., Soden, P. E., Gray, R., Topps, S., Howlett, D. R., Lavender, D., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00389-0 · Cited by 85 · see citing works
Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis
Moechars, D., Lorent, K., & Leuven, F. V. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00599-5 · Cited by 69 · see citing works
Neurobiology of Alzheimer's Disease
Watson, R. A. (2002) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2002.02280_2.x · Cited by 30 · see citing works

Flagged first, then by citations

Sorted by citations

Alzheimer disease models and human neuropathology: similarities and differences
Duyckaerts, C. J., Potier, M., & Delatour, B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 441 · see citing works
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease
Thambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., Zhang, Y., Wahlund, L.-O., Westman, E., Kinsey, A., Güntert, A., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.78 · Cited by 405 · see citing works
Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults
Buckley, R. F., Mormino, E. C., Rabin, J. S., Hohman, T. J., Landau, S., Hanseeuw, B. J., Jacobs, H. I. L., Papp, K. V., Amariglio, R. E., Properzi, M. J., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4693 · Cited by 373 · see citing works
Intracerebral Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Amyloid-Beta Deposition and Rescues Memory Deficits in Alzheimer's Disease Mice by Modulation of Immune Responses
Lee, J. K., Jin, H. K., Endo, S., Schuchman, E. H., Carter, J., & Bae, J.-S. (2009) · Stem Cells · doi:10.1002/stem.277 · Cited by 303 · see citing works
GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models
Medhurst, A. D., Atkins, A. R., Beresford, I. J. M., Brackenborough, K. T., Briggs, M. A., Calver, A. R., Cilia, J., Cluderay, J. E., Crook, B., Davis, J. B., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120311 · Cited by 302 · see citing works
Sex, amyloid, and <i>APOE</i> ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts
Buckley, R. F., Mormino, E. C., Amariglio, R. E., Properzi, M. J., Rabin, J. S., Lim, Y. Y., Papp, K. V., Jacobs, H. I. L., Burnham, S., Hanseeuw, B. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.04.010 · Cited by 276 · see citing works
Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents
Grayson, B., Léger, M., Piercy, C., Adamson, L., Harte, M., & Neill, J. C. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.10.025 · Cited by 246 · see citing works
Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
Bagheri, S., Squitti, R., Haertlé, T., Siotto, M., & Saboury, A. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00446 · Cited by 231 · see citing works
Oral administration of a potent and selective non‐peptidic BACE‐1 inhibitor decreases β‐cleavage of amyloid precursor protein and amyloid‐β production in vivo
Hussain, I., Hawkins, J., Harrison, D. C., Hille, C. J., Wayne, G. J., Cutler, L., Buck, T., Walter, D. S., Demont, E. H., Howes, C., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04260.x · Cited by 197 · see citing works
Imaging and spatial distribution of β-amyloid peptide and metal ions in Alzheimer’s plaques by laser ablation–inductively coupled plasma–mass spectrometry
Hutchinson, R. W., Cox, A. G., McLeod, C. W., Marshall, P. S., Harper, A. J., Dawson, E. L., & Howlett, D. R. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.08.024 · Cited by 189 · see citing works
β-amyloid activates PARP causing astrocytic metabolic failure and neuronal death
Abeti, R., Abramov, A. Y., & Duchen, M. R. (2011) · Brain · doi:10.1093/brain/awr104 · Cited by 172 · see citing works
MAPK-activated Protein Kinase 2 Deficiency in Microglia Inhibits Pro-inflammatory Mediator Release and Resultant Neurotoxicity
Culbert, A. A., Skaper, S. D., Howlett, D. R., Evans, N. A., Facci, L., Soden, P. E., Seymour, Z. M., Guillot, F., Gaestel, M., & Richardson, J. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513646200 · Cited by 170 · see citing works
Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression
Cole, A. R., Noble, W. J., van Aalten, L., Plattner, F., Meimaridou, R., Hogan, D., Taylor, M., LaFrancois, J. J., Gunn‐Moore, F. J., Verkhratsky, A., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04829.x · Cited by 166 · see citing works
NMDA-Mediated Ca2+Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice
Goussakov, I. V., Miller, M. B., & Stutzmann, G. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2474-10.2010 · Cited by 162 · see citing works
Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology
Kosel, F., Pelley, J. M. S., & Franklin, T. B. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.012 · Cited by 162 · see citing works
The medial prefrontal cortex - hippocampus circuit that integrates information of object, place and time to construct episodic memory in rodents: Behavioral, anatomical and neurochemical properties
Chao, O. Y., de Souza Silva, M. A., Yang, Y.-M., & Huston, J. P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.007 · Cited by 158 · see citing works
Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer’s disease pathogenesis
Zhu, L., Zhong, M., Elder, G. A., Sano, M., Holtzman, D. M., Gandy, S., Cardozo, C., Haroutunian, V., Robakis, N. K., & Cai, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510011112 · Cited by 160 · see citing works
Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease
Searcy, J. L., Phelps, J. T., Pancani, T., Kadish, I., Popovic, J., Anderson, K. L., Beckett, T. L., Murphy, M. P., Chen, K.-C., Blalock, E. M., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111661 · Cited by 154 · see citing works
Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease
Lau, J. C., Lerch, J. P., Sled, J. G., Henkelman, R. M., Evans, A. C., & Bedell, B. J. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.252 · Cited by 151 · see citing works
Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer’s disease
Lee, J. K., Jin, H. K., Park, M. H., Kim, B.-R., Lee, P. H., Nakauchi, H., Carter, J., He, X., Schuchman, E. H., & Bae, J. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132451 · Cited by 147 · see citing works
Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD)
Filali, M., Lalonde, R., Thériault, P., Julien, C., Calon, F., & Planel, E. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.004 · Cited by 139 · see citing works
Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease
Chakroborty, S., Briggs, C. A., Miller, M. B., Goussakov, I. V., Schneider, C., Kim, J. S., Wicks, J. M., Richardson, J. C., Conklin, V., Cameransi, B. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052056 · Cited by 136 · see citing works
Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease
Pugh, P. L., Richardson, J. C., Bate, S. T., Upton, N., & Sunter, D. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.11.044 · Cited by 135 · see citing works
Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits
Jardanhazi‐Kurutz, D., Kummer, M. P., Terwel, D., Vogel, K., Dyrks, T., Thiele, A., & Heneka, M. T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.02.001 · Cited by 133 · see citing works
Non-invasive infra-red therapy (1072 nm) reduces β-amyloid protein levels in the brain of an Alzheimer’s disease mouse model, TASTPM
Grillo, S. L., Duggett, N. A., Ennaceur, A., & Chazot, P. L. (2013) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2013.02.015 · Cited by 114 · see citing works
Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders
Ullah, M. F., Ahmad, A., Bhat, S. H., Abuduhier, F. M., Barreto, G. E., & Ashraf, G. M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.003 · Cited by 113 · see citing works
Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model
Sil, A., Erfani, A., Lamb, N., Copland, R., Riedel, G., & Platt, B. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-210523 · Cited by 109 · see citing works
Role of endoplasmic reticulum Ca2+ signaling in the pathogenesis of Alzheimer disease
Александровна, П. Е., & Борисович, Б. И. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00029 · Cited by 107 · see citing works
Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP×PS1 mice using MRI
Maheswaran, S., Barjat, H., Rueckert, D., Bate, S. T., Howlett, D. R., Tilling, L. C., Smart, S., Pohlmann, A., Richardson, J. C., Hartkens, T., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.045 · Cited by 103 · see citing works
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research
Dennison, J. L., Ricciardi, N. R., Lohse, I., Volmar, C., & Wahlestedt, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201014 · Cited by 100 · see citing works
Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer’s Disease
Lee, J. Y., Han, S. H., Park, M. H., Baek, B., Song, I., Choi, M.-K., Takuwa, Y., Ryu, H., Kim, S. H., He, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03674-2 · Cited by 97 · see citing works
Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
Nisticò, R., Pignatelli, M., Piccinin, S., Mercuri, N. B., & Collingridge, G. L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8324-3 · Cited by 97 · see citing works
The role of positive selection in determining the molecular cause of species differences in disease
Vamathevan, J. J., Hasan, S., Emes, R. D., Amrine‐Madsen, H., Rajagopalan, D., Topp, S. D., Kumar, V. D., Word, M., Simmons, M. D., Foord, S. M., et al. (2008) · BMC Evolutionary Biology · doi:10.1186/1471-2148-8-273 · Cited by 98 · see citing works
Viscoelasticity of amyloid plaques in transgenic mouse brain studied by Brillouin microspectroscopy and correlative Raman analysis
Mattana, S., Caponi, S., Tamagnini, F., Fioretto, D., & Palombo, F. (2017) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545817420019 · Cited by 92 · see citing works
Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer’s disease mouse models
Huang, Y., Skwarek‐Maruszewska, A., Horré, K., Vandewyer, E., Wolfs, L., Snellinx, A., Saito, T., Radaelli, E., Corthout, N., Colombelli, J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab3492 · Cited by 90 · see citing works
Gender- and Age-Dependent γ-Secretase Activity in Mouse Brain and Its Implication in Sporadic Alzheimer Disease
Placanica, L., Zhu, L., & Li, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005088 · Cited by 88 · see citing works
Dietary (−)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing
Cox, C. J., Choudhry, F., Peacey, E., Perkinton, M. S., Richardson, J. C., Howlett, D. R., Lichtenthaler, S. F., Francis, P. T., & Williams, R. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.032 · Cited by 87 · see citing works
Age-dependent disruption in hippocampal theta oscillation in amyloid-β overproducing transgenic mice
Scott, L., Feng, J., Kiss, T., Needle, E., Atchison, K. P., Kawabe, T. T., Milici, A. J., Hajós‐Korcsok, É., Riddell, D. R., & Hajós, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.010 · Cited by 87 · see citing works
Behavioral and neurobiological effects of prenatal stress exposure in male and female APPswe/PS1dE9 mice
Sierksma, A. S. R., Prickaerts, J., Chouliaras, L., Rostamian, S., Delbroek, L., Rutten, B. P. F., Steinbusch, H. W. M., & van den Hove, D. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.012 · Cited by 87 · see citing works
Locus coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease
Ross, J. A., McGonigle, P., & Bockstaele, E. J. V. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2015.09.002 · Cited by 85 · see citing works
The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease
Bonham, L. W., Sirkis, D. W., & Yokoyama, J. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01170 · Cited by 83 · see citing works
Impairment of hippocampal gamma (γ)‐frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP)
Driver, J. E., Racca, C., Cunningham, M. O., Towers, S. K., Davies, C. H., Whittington, M. A., & LeBeau, F. E. N. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05705.x · Cited by 80 · see citing works
First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression
Cummings, D. M., Liu, W., Portelius, E., Bayram, S., Yasvoina, M. V., Ho, H., Smits, H., Ali, S. S., Steinberg, R., Pegasiou, C.-M., et al. (2015) · Brain · doi:10.1093/brain/awv127 · Cited by 81 · see citing works
Gender-specificities in Alzheimer's disease and mild cognitive impairment
Beinhoff, U., Tumani, H., Brettschneider, J., Bittner, D., & Riepe, M. W. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0726-9 · Cited by 79 · see citing works
MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer’s disease pathogenesis
Cao, J., Huang, M., Guo, L., Zhu, L., Hou, J., Zhang, L., Pero, A., Ng, S., Gaamouch, F. E., Elder, G. A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0824-3 · Cited by 79 · see citing works
Altered Cortical and Hippocampal Excitability in TgF344-AD Rats Modeling Alzheimer’s Disease Pathology
Stoiljković, M., Kelley, C., Stutz, B., Horváth, T. L., & Hajós, M. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy140 · Cited by 72 · see citing works
Telomeres and telomerase in Alzheimer's disease: Epiphenomena or a new focus for therapeutic strategy?
Franco, S., Blasco, M. A., Siedlak, S. L., Harris, P. L. R., Moreira, P. I., Perry, G. L., & Smith, M. A. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.03.001 · Cited by 74 · see citing works
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79 · see citing works
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration
Chai, Y. L., Chong, J. R., Weng, J., Howlett, D., Halsey, A., Lee, J. H., Attems, J., Aarsland, D., Francis, P. T., Chen, C. P., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12631 · Cited by 73 · see citing works
PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease
Torres, J. B., Andreozzi, E. M., Dunn, J., Siddique, M., Szanda, I., Howlett, D. R., Sunassee, K., & Blower, P. J. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.162370 · Cited by 67 · see citing works
Reduction of Synaptojanin 1 Accelerates Aβ Clearance and Attenuates Cognitive Deterioration in an Alzheimer Mouse Model
Zhu, L., Zhong, M., Zhao, J., Rhee, H., Caesar, I., Knight, E. M., Volpicelli-Daley, L., Bustos, V., Netzer, W., Liu, L., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.504365 · Cited by 70 · see citing works
What do we know about the long-term consequences of stress on ageing and the progression of age-related neurodegenerative disorders?
Pardon, M., & Rattray, I. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.005 · Cited by 65 · see citing works
Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
Howlett (2008) · PubMed · doi:10.14670/hh-23.67 · Cited by 65 · see citing works
Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action
Luo, Y., Sun, Y., Tian, X., Zheng, X., Wang, X., Li, W., Wu, X., Shu, B., & Hou, W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.619543 · Cited by 65 · see citing works
CRMP2 Hyperphosphorylation is Characteristic of Alzheimer's Disease and not a Feature Common to Other Neurodegenerative Diseases
Williamson, R., van Aalten, L., Mann, D. M. A., Platt, B., Plattner, F., Bedford, L., Mayer, J., Howlett, D. R., Usardi, A., Sutherland, C. D., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110617 · Cited by 64 · see citing works
Sex and Gender Differences in Alzheimer’s Disease: Genetic, Hormonal, and Inflammation Impacts
Kolahchi, Z., Henkel, N., Eladawi, M. A., Villarreal, E. C., Kandimalla, P., Lundh, A., McCullumsmith, R. E., & Cuevas, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158485 · Cited by 63 · see citing works
Clusterin Associates Specifically with <scp>A</scp>β40 in <scp>A</scp>lzheimer's Disease Brain Tissue
Howlett, D. R., Hortobágyi, T., & Francis, P. T. (2013) · Brain Pathology · doi:10.1111/bpa.12057 · Cited by 51 · see citing works
APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD)
Lalonde, R., Fukuchi, K., & Strazielle, C. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.011 · Cited by 62 · see citing works
Modeling Alzheimer’s disease: from past to future
Saraceno, C., Musardo, S., Marcello, E. E., Pelucchi, S., & Luca, M. D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00077 · Cited by 61 · see citing works
Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease
Willuweit, A., Velden, J., Godemann, R., Manook, A., Jetzek, F., Tintrup, H., Kauselmann, G., Zevnik, B., Henriksen, G., Drzezga, A. E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007931 · Cited by 60 · see citing works
A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease
Bonardi, C., de Pulford, F., Jennings, D. J., & Pardon, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.041 · Cited by 59 · see citing works
Metabonomic Profiling of TASTPM Transgenic Alzheimer’s Disease Mouse Model
Hu, Z., Browne, E. R., Liu, T., Angel, T. E., Ho, P. C., & Chan, E. C. Y. (2012) · Journal of Proteome Research · doi:10.1021/pr300666p · Cited by 58 · see citing works
Changes in Brain β-Amyloid Deposition and Aquaporin 4 Levels in Response to AlteredAgrinExpression in Mice
Rauch, S. M., Huen, K. H. Y., Miller, M. C., Chaudry, H., Lau, M., Sanes, J. R., Johanson, C. E., Stopa, E. G., & Burgess, R. W. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31823b0b12 · Cited by 57 · see citing works
Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over‐expressing TASTPM mice
Medhurst, A. D., Roberts, J., Lee, J., Chen, C., Brown, S., Roman, S. A., & Lai, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00075.x · Cited by 57 · see citing works
Anesthesia in presymptomatic Alzheimer's disease: A study using the triple‐transgenic mouse model
Tang, J. X., Mardini, F., Caltagarone, B. M., Garrity, S. T., Li, R. Q., Bianchi, S. L., Gomes, O., LaFerla, F. M., Eckenhoff, R. G., & Eckenhoff, M. F. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.10.003 · Cited by 57 · see citing works
Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice
Park, M. H., Lee, J. K., Choi, S., Ahn, J., Jin, H. K., Park, J., & Bae, J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.05.045 · Cited by 57 · see citing works
Sex and gonadal hormones in mouse models of Alzheimer’s disease: what is relevant to the human condition?
Dubal, D. B., Broestl, L., & Worden, K. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-24 · Cited by 58 · see citing works
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium‐derived factor: Two novel biomarkers of Alzheimer's disease in human plasma
Cutler, P., Akuffo, E. L., Bodnar, W. M., Briggs, D. M., Davis, J. B., Debouck, C. M., Fox, S. M., Gibson, R. A., Gormley, D. A., Holbrook, J. D., et al. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780101 · Cited by 55 · see citing works
Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer’s disease
Yang, J., Kou, J., Lalonde, R., & Fukuchi, K.-I. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.05.012 · Cited by 55 · see citing works
18F-FDG-PET in Mouse Models of Alzheimer's Disease
Bouter, C., & Bouter, Y. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00071 · Cited by 51 · see citing works
N , N ′-Diacetyl- p -phenylenediamine restores microglial phagocytosis and improves cognitive defects in Alzheimer’s disease transgenic mice
Park, M. H., Lee, M., Nam, G., Kim, M., Kang, J., Choi, B. J., Jeong, M. S., Park, K. H., Han, W. H., Tak, E., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916318116 · Cited by 54 · see citing works
N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer’s disease
Lee, J. Y., Han, S. H., Park, M. H., Song, I., Choi, M., Yu, E., Park, C., Kim, H.-J., Kim, S. H., Schuchman, E. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16080-4 · Cited by 53 · see citing works
Prenatal exposure to chronic mild stress increases corticosterone levels in the amniotic fluid and induces cognitive deficits in female offspring, improved by treatment with the antidepressant drug amitriptyline
Aziz, N. H. K. A., Kendall, D. A., & Pardon, M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.02.040 · Cited by 50 · see citing works
Sex specific molecular networks and key drivers of Alzheimer’s disease
Guo, L., Cao, J., Hou, J., Li, Y., Huang, M., Zhu, L., Zhang, L., Lee, Y., Duarte, M. L., Zhou, X., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00624-5 · Cited by 49 · see citing works
Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade
Belkacemi, A., & Ramassamy, C. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.020 · Cited by 49 · see citing works
Body mass index and mild cognitive impairment among rural older adults in China: the moderating roles of gender and age
Yuan, Y., Li, J., Zhang, N., Fu, P., Jing, Z., Yu, C., Zhao, D., Hao, W., & Zhou, C. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03059-8 · Cited by 46 · see citing works
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia
Micale, V., Leggio, G. M., Mazzola, C., & Drago, F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.108 · Cited by 46 · see citing works
Circadian System Functionality, Hippocampal Oxidative Stress, and Spatial Memory in the APPswe/PS1dE9 Transgenic Model of Alzheimer Disease: Effects of Melatonin or Ramelteon
Baño‐Otálora, B., Popovic, N., Gambini, J., Popović, M., Viña, J., Bonet-Costa, V., Reiter, R. J., Camello, P. J., Rol, M. A., & Madrid, J. A. (2012) · Chronobiology International · doi:10.3109/07420528.2012.699119 · Cited by 46 · see citing works
Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS☆
Woo, D., Lee, S., Lee, D., Kim, S.-Y., Kim, G., Rhim, H., Choi, C., Kim, H., Lee, C., & Choe, B. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.026 · Cited by 45 · see citing works
Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis
Scullion, G. A., Kendall, D. A., Marsden, C. A., Sunter, D., & Pardon, M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.002 · Cited by 44 · see citing works
Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease (Erratum)
Chouliaras, L., Sierksma, A. S. R., Kenis, G., Prickaerts, J., Lemmens, M. A. M., Brasnjevic, I., van Donkelaar, E. L., Martínez‐Martínez, P., Losen, M. H., Baets, M. H. D., et al. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/356862 · Cited by 44 · see citing works
Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice
Choudhry, F., Howlett, D. R., Richardson, J. C., Francis, P. T., & Williams, R. J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.008 · Cited by 43 · see citing works
Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease
Spencer, J. P., Brown, J. T., Richardson, J. C., Medhurst, A. D., Sehmi, S. S., Calver, A. R., & Randall, A. D. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.070 · Cited by 43 · see citing works
Detection of Aβ plaque-associated astrogliosis in Alzheimer's disease brain by spectroscopic imaging and immunohistochemistry
Palombo, F., Tamagnini, F., Jeynes, J. C. G., Mattana, S., Swift, I. J., Nallala, J., Hancock, J. M., Brown, J. T., Randall, A. D., & Stone, N. (2017) · The Analyst · doi:10.1039/c7an01747b · Cited by 39 · see citing works
Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease
Lok, K., Hong, Z., Zhang, C. M., He, N., Shen, H., Wang, Z., Zhao, W., & Yin, M. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.09.018 · Cited by 40 · see citing works
Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels
Pardon, M., Sarmad, S., Rattray, I., Bates, T. E., Scullion, G. A., Marsden, C. A., Barrett, D. A., Lowe, J. S., & Kendall, D. A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.002 · Cited by 39 · see citing works
Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease
Campbell, S. N., Zhang, C., Roe, A. D., Lee, N., Lao, K., Monte, L., Donohue, M., & Rissman, R. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142844 · Cited by 39 · see citing works
The Continuing Failure of Bexarotene in Alzheimer’s Disease Mice
Balducci, C., Paladini, A., Micotti, E., Tolomeo, D., Vitola, P. L., Grigoli, E., Richardson, J. C., & Forloni, G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150029 · Cited by 37 · see citing works
Early development of social deficits in APP and APP-PS1 mice
Pietropaolo, S., Delage, P., Lebreton, F., Crusio, W. E., & Cho, Y. H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.012 · Cited by 36 · see citing works
Transgenic mice over-expressing human β-amyloid have functional nicotinic alpha 7 receptors
Spencer, J. P., Weil, A., Hill, K., Hussain, I., Richardson, J. C., Cusdin, F. S., Chen, Y. H., & Randall, A. D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.007 · Cited by 35 · see citing works
Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APPSwe/PSEN1M146V transgenic mice
Medawar, E., Benway, T. A., Liu, W., Hanan, T. A., Haslehurst, P., James, O. T., Yap, K., Muessig, L., Moroni, F., Nahaboo Solim, M. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.006 · Cited by 26 · see citing works
Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease
Aman, Y., Pitcher, T., Simeoli, R., Ballard, C. G., & Malcangio, M. (2016) · Pain · doi:10.1097/j.pain.0000000000000644 · Cited by 33 · see citing works
Gene Therapy Models of Alzheimer’s Disease and Other Dementias
Combs, B., Kneynsberg, A., & Kanaan, N. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3271-9_25 · Cited by 31 · see citing works
Sex difference in biological change and mechanism of Alzheimer’s disease: From macro- to micro-landscape
Cui, S., Jiang, Q., & Chen, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101918 · Cited by 30 · see citing works
Exercise preconditioning improves behavioral functions following transient cerebral ischemia induced by 4-vessel occlusion (4-VO) in rats.
Tahamtan, M., Allahtavakoli, M., Abbasnejad, M., Roohbakhsh, A., Taghipour, Z., Taghavi, M., Khodadadi, H., & Shamsizadeh, A. (2013) · PubMed · Cited by 31 · see citing works
One‐year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice
Cudennec, C. L., Faure, A., Ly, M., & Delatour, B. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00374.x · Cited by 31 · see citing works
Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease
Chouliaras, L., Sierksma, A. S. R., Kenis, G., Prickaerts, J., Lemmens, M. A. M., Brasnjevic, I., van Donkelaar, E. L., Martínez‐Martínez, P., Losen, M. H., Baets, M. H. D., et al. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/859101 · Cited by 30 · see citing works
F-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice
Hafez, D. M., Huang, J., Richardson, J. C., Masliah, E., Peterson, D. A., & Marr, R. A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.038 · Cited by 29 · see citing works
Analysis of serial magnetic resonance images of mouse brains using image registration
Maheswaran, S., Barjat, H., Bate, S. T., Aljabar, P., Hill, D., Tilling, L. C., Upton, N., James, M. F., Hajnal, J. V., & Rueckert, D. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.016 · Cited by 30 · see citing works
Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain
Yue, X., Zhou, Y., Qiao, M., Zhao, X., Huang, X. H., Zhao, T., Cheng, X., Fan, M., Zhao, Y., Chen, R., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00935-z · Cited by 29 · see citing works

PS2APP Transgenic Mice, Coexpressing hPS2mut and hAPPswe, Show Age-Related Cognitive Deficits Associated with Discrete Brain Amyloid Deposition and Inflammation
Richards, J. G., Higgins, G. A., Ouagazzal, A., Ozmen, L., Kew, J. N. C., Bohrmann, B., Malherbe, P., Brockhaus, M., Loetscher, H., Czech, C., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08989.2003 · Cited by 200 · see citing works
Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice
Gordon, M. N., King, D. L., Diamond, D. M., Jantzen, P. T., Boyett, K. W., Hope, C. E., Hatcher-Martin, J. M., DiCarlo, G., Gottschall, W. P. E., Morgan, D., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00249-9 · Cited by 199 · see citing works
Cyril Clarke, Journal of Medical Genetics, and the foundation of clinical genetics
Harper, P. S. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.5.283
P1–052: A decrease in cortical synapse density does not appear to underlie early cognitive deficits in the TASTPM mouse model of Alzheimer's disease
Thaker, U., Howlett, D. R., & Davies, D. C. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.427
Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes
Arendash, G. W., King, D. L., Gordon, M. N., Morgan, D., Hatcher, J. M., Hope, C. E., & Diamond, D. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03186-3 · Cited by 349 · see citing works

Authors: Howlett, D. R., Richardson, J. C., Austin, A., Parsons, A. A., Bate, S. T., Davies, D. C., & Gonzalez, M. I.
Affiliations: GlaxoSmithKline (United Kingdom) (GB)
St George's Hospital (GB)
Corresponding author: Howlett, David R
ORCID: Howlett, David R
Richardson, Jill C
Bate, Simon T
Venue: Brain Research
Publisher: Elsevier BV
Published: 2004-08
Volume: 1017
Issue: 1-2
Pages: 130-136
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/j.brainres.2004.05.029
OpenAlex: W2048622057
Cited by: 212
References: 41
Citations by year: 2026: 2 · 2025: 1 · 2024: 21 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 12 · 2019: 6 · 2018: 17 · 2017: 5 · 2016: 6 · 2015: 13 · 2014: 6 · 2013: 14 · 2012: 15
FWCI: 3.91
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, amyloid-beta deposition, presenilin 1 mutations, amyloid precursor protein mutations, cognitive impairment, object recognition, sex differences, amyloid plaques, neuronal connectivity
MeSH terms: Age Factors, Alzheimer Disease, Analysis of Variance, Animals, Behavior, Animal, Cerebral Cortex, Disease Models, Animal, Female, Immunohistochemistry, Male, Membrane Proteins, Mice, Transgenic, Microscopy, Electron, Mutation, Neuropsychological Tests, Sex Characteristics, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice, Presenilin-1, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks